Keywords: Meda, Zyclara, Actinic keratosis, Europe, Approval

Meda's Zyclara approved in the EU

Article | 29 August 2012

Sweden-based Meda (OMX: MEDA A) yesterday announced that the European Commission has granted marketing authorization for Zyclara (imiquimod 3.75% cream), a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Meda

Go to company listing

Related Drugs

Zyclara

Go to drug listing